AMILORIDE

Clinical Indication

Heart failure and hypertension in infants and children

Comments

Full SCA

Date of classification

December 2013

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.